DK569082A - Quinolyleddikesyreforbindelser og pharmaceutiske blandinger indeholdende disse forbindelser - Google Patents

Quinolyleddikesyreforbindelser og pharmaceutiske blandinger indeholdende disse forbindelser Download PDF

Info

Publication number
DK569082A
DK569082A DK569082A DK569082A DK569082A DK 569082 A DK569082 A DK 569082A DK 569082 A DK569082 A DK 569082A DK 569082 A DK569082 A DK 569082A DK 569082 A DK569082 A DK 569082A
Authority
DK
Denmark
Prior art keywords
group
carbon atoms
hydrogen atom
member selected
compounds
Prior art date
Application number
DK569082A
Other languages
Danish (da)
English (en)
Inventor
Masaaki Hamada
Kaoru Okamoto
Teikichi Kurosaki
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Publication of DK569082A publication Critical patent/DK569082A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK569082A 1981-12-29 1982-12-23 Quinolyleddikesyreforbindelser og pharmaceutiske blandinger indeholdende disse forbindelser DK569082A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56211626A JPS58116466A (ja) 1981-12-29 1981-12-29 新規キノリル酢酸誘導体及び該化合物を含有する医薬組成物

Publications (1)

Publication Number Publication Date
DK569082A true DK569082A (da) 1983-06-30

Family

ID=16608881

Family Applications (1)

Application Number Title Priority Date Filing Date
DK569082A DK569082A (da) 1981-12-29 1982-12-23 Quinolyleddikesyreforbindelser og pharmaceutiske blandinger indeholdende disse forbindelser

Country Status (10)

Country Link
US (1) US4555513A (zh)
EP (1) EP0083222B1 (zh)
JP (1) JPS58116466A (zh)
KR (1) KR840002813A (zh)
AT (1) ATE18211T1 (zh)
AU (1) AU559732B2 (zh)
CA (1) CA1192198A (zh)
DE (1) DE3269533D1 (zh)
DK (1) DK569082A (zh)
ES (1) ES8406442A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0317061A (ja) * 1989-06-13 1991-01-25 Kyorin Pharmaceut Co Ltd 新規環状アントラニル酸酢酸誘導体
JP3209568B2 (ja) * 1991-04-16 2001-09-17 杏林製薬株式会社 新規環状アミノフェニル酢酸誘導体、その製造法及びそれらを有効成分とする免疫応答の修飾剤
US5666014A (en) * 1994-07-20 1997-09-09 Mechanical Technology Inc. Velocity-controlled magnetic bearings
US5776482A (en) * 1996-03-29 1998-07-07 University Of Iowa Research Foundation Tetrahydroquinoline analogues for use in glaucoma treatment
GB9818641D0 (en) * 1998-08-26 1998-10-21 Rh Ne Poulenc Rorer Limited Chemical compounds
EP1807080A1 (en) * 2004-10-29 2007-07-18 AstraZeneca AB Use of unsaturated quionoline or naphtalene derivatives as medicaments

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2042352A1 (fr) * 1969-04-21 1971-02-12 Ciba Geigy Ag Acides alpha-(1,2,3,4-tetrahydro-6-quinolyl)-carboxyliques et leurs derives
CH576447A5 (zh) * 1972-03-10 1976-06-15 Ciba Geigy Ag
FR2278338A1 (fr) * 1974-07-15 1976-02-13 Bouchara Emile Derives de la dihydro-1-2 trimethyl-2-2-4 quinoleine et application comme medicaments
CH628892A5 (it) * 1977-06-22 1982-03-31 Simes Procedimento per la preparazione di acidi chinolinici ad attivita antiinfiammatoria.
JPS54128584A (en) * 1978-03-28 1979-10-05 Teijin Ltd Novel 3,4-dihydrocarbostyril derivative

Also Published As

Publication number Publication date
ATE18211T1 (de) 1986-03-15
JPS58116466A (ja) 1983-07-11
KR840002813A (ko) 1984-07-21
ES518613A0 (es) 1984-08-01
CA1192198A (en) 1985-08-20
AU559732B2 (en) 1987-03-19
EP0083222B1 (en) 1986-02-26
EP0083222A1 (en) 1983-07-06
AU9181382A (en) 1983-07-07
JPH037670B2 (zh) 1991-02-04
ES8406442A1 (es) 1984-08-01
DE3269533D1 (en) 1986-04-03
US4555513A (en) 1985-11-26

Similar Documents

Publication Publication Date Title
ES465384A1 (es) Procedimiento para la obtencion de ciclopentan-1-aminas
DE2960820D1 (en) Carbostyrile derivatives, processes for their preparation and pharmaceutical compositions containing them
ES8401961A1 (es) Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas.
ES8507090A1 (es) Procedimiento para la obtencion de nuevas 1, 5-benzotiacepinas
ES466366A1 (es) Un procedimiento para preparar derivados de metasulfonamido-benzamida.
DE3266708D1 (en) Pyridazinone derivatives, process for their preparation and their use as fungicides
DK569082A (da) Quinolyleddikesyreforbindelser og pharmaceutiske blandinger indeholdende disse forbindelser
DK511383D0 (da) Fremgangsmade til fremstilling af piperidindionderivater,der beskytter hjertemuskulaturen med en antiarythmisk aktivitet
DK67384A (da) N-iminopyridiniumbetainderivater
ATE32894T1 (de) Thiomethylpyridin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
ATE17352T1 (de) Cephalosporinverbindungen, ihre herstellung und sie enthaltende medikamente.
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
IL60176A0 (en) Xanthine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
DK513281A (da) Fremgangsaade til fremstilling af 3-thiovinylcephalosproner
SE8302452D0 (sv) Method for treatment of senile dementia
ES8103047A1 (es) Procedimiento de preparacion de derivados aminoisoquinolinosasi como de sus sales de adicion acidas, farmaceuticamente aceptables y de sus derivados amonicos cuaternarios
ES483303A1 (es) Un procedimiento para la preparacion de derivados de benzo- diacepina
ES484086A1 (es) Procedimiento para la preparacion de compuestos de isopropi-lamina
GB2022583A (en) New ionic polyiodo benzene derivatives useful as X-ray contrast media
IE832769L (en) Acridanone derivative.
ATE36536T1 (de) Phosphoroimidate.
ES481416A1 (es) Un procedimiento para la preparacion de un derivado monoami-da de acido tereftalico.
ES483300A1 (es) Un procedimiento para la preparacion de derivados de benzo- diacepina
DK727388A (da) 2-aminotetrahydroisoquinolinderivater, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment